AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
What is the latest Total Expenditure of AUROBINDO PHARMA ?
Year | Total Expenditure |
---|---|
Mar2025 | ₹25,141 Cr |
Mar2024 | ₹23,159 Cr |
Mar2023 | ₹21,137 Cr |
Mar2022 | ₹19,071 Cr |
Mar2021 | ₹19,441 Cr |
How is Total Expenditure of AUROBINDO PHARMA Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2025 | ₹25,141 Cr | 8.56 | |
Mar2024 | ₹23,159 Cr | 9.57 | |
Mar2023 | ₹21,137 Cr | 10.83 | |
Mar2022 | ₹19,071 Cr | -1.90 | |
Mar2021 | ₹19,441 Cr | - |
Compare Total Expenditure of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,953.8 Cr | 1.8% | 6.9% | -27.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.8% |
6.9% |
-27.3% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses